The US Food and Drug Administration has granted full approval for Moderna’s COVID-19 vaccine for children under 12, but only for those at increased risk of severe illness. This decision aligns with Health Secretary Robert F. Kennedy Jr.’s controversial stance limiting broad pediatric access to the vaccine. Previously, Moderna and Pfizer COVID-19 shots were available to all children under emergency use. Moderna’s stock surged up to 4.2% following the news. The move marks a shift in US policy on pediatric COVID-19 vaccination post-emergency phase. COVID-19 Jabs Safe as ICMR, AIIMS Studies Find No Link Between Coronavirus Vaccine and Sudden Deaths, Says Centre.

Moderna’s COVID-19 Vaccine Gets US FDA Nod

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)